About the book:

The experience of hydroxychloroquine in managing RA patients with diabetes mellitus suggested the anti-diabetic potential of the drug. The anti-diabetic effect has been effectively proven by clinical trials and the drug has been recently approved for managing diabetes. Emerging studies suggest its clinical use in obstetrical antiphospholipid syndrome (APS) and other recurrent pregnancy loss, especially in refractory cases. Several studies are being conducted to determine whether hydroxychloroquine should be recommended as a part of APS treatment. The immune modulation potential of the drug has also been investigated for the management of cancer.

In this book author has made attempt to clarify all the queries related to the clinical use of hydroxychloroquine in managing diabetes.

Edition

First edition

Edition

1

ISBN

978-81-932500-4-4

Year

2018

Author

Dr. Chandrashekara S

Pages

32

ISBN

978-81-932500-4-4

Pages

32

Year

2018

Author

Dr. Chandrashekara. S